US startup No Barrier has raised $2.7 million in an oversubscribed seed round. Lead investors are A-Squared Ventures and Esplanade Ventures, with participation from Rock Health Capital and Fusion Fund.
The platform offers AI-powered real-time translation and interpretation in over 40 languages, specifically developed for clinical use. It integrates seamlessly into existing workflows and electronic health records and meets strict HIPAA and SOC-2 security requirements.
This provides healthcare facilities with an immediately available, privacy-compliant alternative to traditional external interpretation services – without waiting times and at up to 70 percent lower costs. More than 25.7 million people in the US have limited English proficiency; language barriers often lead to delayed diagnoses and higher complication rates.
No Barrier is already used in over 100 clinics and practices in twelve states, including in psychiatry, reproductive medicine, and pediatrics. By eliminating the need for external interpreters in sensitive conversations, patient privacy is better protected and trust in treatment is strengthened.
The fresh capital will be used for accelerated scaling and expansion of integration into further care areas along the entire patient pathway.
Sources:
- HIT Consultant Media / Syed Hamza Sohail: No Barrier Raises $2.7M to Scale AI-Powered Medical Translation and Access, November 17, 2025
- No Barrier Press Release, November 17, 2025
